Post reply

The message has the following error or errors that must be corrected before continuing:
Warning: this topic has not been posted in for at least 365 days.
Unless you're sure you want to reply, please consider starting a new topic.
Other options
Verification:
Please leave this box empty:
Type the letters shown in the picture
Listen to the letters / Request another image

Type the letters shown in the picture:
Please spell spammer backwards:
Three blonde, blue-eyed siblings are named Suzy, Jack and Bill.  What color hair does the sister have?:
Shortcuts: ALT+S post or ALT+P preview

Topic summary

Posted by spacecanada
 - January 13, 2016, 03:22:24 PM
Agreed, CM.
Posted by CMdeux
 - January 13, 2016, 02:07:15 PM
HUGE step in the right direction, this study.


Quote
We did not exclude participants who had a
previous life-threatening reaction, tree-nut allergy, or a
history of severe asthma.

GOOD.   :yes:

Also worth noting that one of the 39 experimental group participants required epinephrine during the study.  Not unexpected, but this is an important feature that has (apparently) been pretty reproducible in OIT trials-- it is also a compelling reason why over-application of exclusion criteria isn't giving a lot of reassurance to those with the lowest thresholds or those with severe asthma/previous severe reaction history to low doses.

This one is different, because it gives a much clearer indication of what that rate of anaphylaxis might be in an unrestricted demographic that undergoes desensitization.

KWIM?